KIM
BMY icon

Karpus Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Karpus Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,712
Closed -$230K – 215
2018
Q3 		$230K Hold
3,712
– – 0.01% 177
2018
Q2 		$207K Buy
+3,712
New +$200K 0.01% 170

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Karpus Investment Management's BMY Position: Q4 2018 in Review

Karpus Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 3,712 shares — an estimated $230K sold.

Karpus Investment Management first reported a position in BMY in Q2 2018 and held it in 2 quarters. The position peaked at $230K in Q3 2018. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • Karpus Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
  • Karpus Investment Management sold 3,712 Bristol-Myers Squibb shares in Q4 2018, an estimated $230K.
  • Karpus Investment Management first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 2 quarters.
  • Karpus Investment Management's Bristol-Myers Squibb position peaked at $230K in Q3 2018.
  • 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Karpus Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.